pharmaphorum

DECEMBER 19, 2022

It would provide an alternative to standard breathing exercises for patients with conditions that affect breathing, including long-term respiratory diseases like asthma, chronic obstructive pulmonary disorder (COPD) and cystic fibrosis, which can be resource-intensive as they require patients to be overseen by a healthcare worker.

Patients 140

Patients Engineering Government Education 140

Pharmaceutical Technology

NOVEMBER 29, 2022

Earlier this month, New Jersey-based Silo Pharma announced the start of an IND-enabling study of a topical ketamine formulation for fibromyalgia, a chronic condition that causes pain and fatigue. Depression research spurs efforts for other conditions. Other companies continue exploring ketamine’s potential in different conditions.

Side effects 110

Side effects Pharmaceutical Patients Medicine 110

Medgadget

OCTOBER 17, 2022

The device is easy to use, requiring the patient to blow into it daily, and the company envisages the technology as similar to the blood-glucose tests used by patients with diabetes to keep track of their condition. Unfortunately, COVID can cause symptoms for patients with chronic lung conditions to worsen severely.

Doctors 93

Doctors FDA Patients Medical 93

World of DTC Marketing

AUGUST 14, 2022

Experts say at least 25% of all outpatient, preventive, long-term care and well-being services could be provided via telehealth by 2040.” Experts say at least 25% of all outpatient, preventive, long-term care and well-being services could be provided via telehealth by 2040.” There it is again.

Doctors 154

Doctors Physicians Healthcare Healthcare 154

Medgadget

OCTOBER 25, 2022

Researchers at Osaka University in Japan engineered a wearable electroencephalography (EEG) device that can measure brain activity, potentially letting clinicians monitor conditions such as depression or dementia. This latest technology aims to allow for at-home measurements of brain activity.

Engineering 113

Engineering Medical Healthcare Healthcare 113

European Pharmaceutical Review

APRIL 26, 2024

Under terms of the deal, Sandoz was given commercialisation rights for Pyzchiva in the US, Canada, the European Economic Area (EEA), Switzerland, and the UK. Under terms of the deal, Sandoz was given commercialisation rights for Pyzchiva in the US, Canada, the European Economic Area (EEA), Switzerland, and the UK.

Food and Drug Administration 52

Food and Drug Administration Medicine Marketing Food 52

European Pharmaceutical Review

MARCH 13, 2023

IIH is a condition that raises pressure in the brain, likely due to a cerebrospinal fluid (CSF) imbalance. Symptoms include chronic headaches and the condition can also lead to pressure on the optic nerve, which can result in blindness. Weight gain is a major risk factor of developing IIH. This was compared to only 1.5

Safety 89

Safety Consulting Patients Leads 89

Pharmacy Times

OCTOBER 20, 2023

Biktarvy was found both effective and safe for long-term use in HIV, as well as for patients with mental health conditions.

Patients 52

Patients 52

European Pharmaceutical Review

OCTOBER 17, 2022

The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO. Conditions include type 1 diabetes, cancer, rheumatoid arthritis and Gaucher disease. Conditions include type 1 diabetes, cancer, rheumatoid arthritis and Gaucher disease.

Manufacturing 90

Manufacturing Pharmaceutical manufacturing Distribution Medicine 90

European Pharmaceutical Review

FEBRUARY 28, 2023

In the simplest terms, the stem cells are injected directly into the heart muscle and shut down inflammation and begin to heal the cells,” he summarised. Based on the findings, Dr Perin explained to EPR that the trial is significant because the condition “currently is not addressed with medications, which treat the symptoms.”

Medical 98

Medical Patients Leads Pharmaceutical 98

European Pharmaceutical Review

JANUARY 15, 2023

As the newest member of the ABPI, the membership will help Moderna to build on its wider long-term commitment to expand its footprint and investment in the UK. Moderna is best known for its work during the COVID-19 pandemic and are now developing a range of mRNA-based vaccines for a number of conditions.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Government 98

World of DTC Marketing

JANUARY 21, 2022

It is evident that HCPs are extremely time constraint and prefer to engage with pharma organizations on their terms regarding channel, content, and type of devices. I maintain a network of thought leaders in several health conditions, and they all have one thing in common: pharma reps and messages are becoming more irrelevant.

Pharma reps 198

Pharma reps Pharma Rep Pharma Media 198

PM360

FEBRUARY 12, 2024

About 4% of the population are affected, with an estimated thirty million currently living with these conditions. About 4% of the population are affected, with an estimated thirty million currently living with these conditions. Grappling with a rare disease diagnosis and navigating limited treatment options can be highly challenging.

Food and Drug Administration 105

Food and Drug Administration Patients Networking Transportation 105

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 92

Side effects Distribution Safety Patients 92

Healthcare Success

MARCH 6, 2024

Achieve long- and short-term goals. We’ll explain how SEM amplifies your web presence quickly and discuss how SEO supports long-term online visibility. Complex medical terms Healthcare organizations must balance complex medical terms and concepts with accurate, accessible, and easy-to-understand content for consumers.

Healthcare 72

Healthcare Healthcare Engineering Marketing 72

World of DTC Marketing

SEPTEMBER 17, 2020

Concerns about the impact of obesity have taken on new dimensions this year as having obesity is one of the underlying health conditions associated with the most serious consequences of COVID infection, including hospitalization and death. While there are lots of reasons for this the silence of healthcare providers is a huge reason.

Healthcare 242

Healthcare Healthcare Insurance Healthcare Provider 242

Rep-Lite

APRIL 4, 2024

Clinical Knowledge: Possessing a basic understanding of relevant medical conditions and procedures related to your devices will enhance your interactions with healthcare providers. Building Trusting Relationships Focus on Long-Term Partnerships: Selling medical devices is not about quick transactions.

Medical 52

Medical Sales Interpersonal Skills Ethics 52

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. In the pharmaceutical industry, content marketing can be particularly effective for driving sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

Medgadget

MAY 19, 2023

This often leaves their associated blood vessels in an unreliable and leaky state, and the center of solid tumors often demonstrates poor blood supply and low-oxygen conditions. Simply using bacteria alone, in specific combinations to achieve maximal efficacy and reduced off-target effects, could represent a low-cost way to target tumors.

Engineering 87

Engineering Leads Medicine 87

Medgadget

NOVEMBER 11, 2022

Importantly, they can assist in very accurately measuring muscle length as the turkeys traversed an obstacle course (yes, really), reflecting real-world conditions outside the lab. However, this approach does not account for muscle activity, in terms of velocity of movement and muscle length during contraction.

Engineering 83

Engineering Patients 83

Impetus Digital

MARCH 15, 2024

Risk prediction can also be particularly important when understanding how different drugs might interact with each other – a vital component for many people with long-term health conditions. This is a guest article and does not necessarily reflect the views and values of Impetus Digital.

Pharma 98

Pharma Medicine Ethics Pharmaceutical 98

pharmaphorum

JULY 12, 2022

With growing numbers of people around the world living with long-term conditions, the pharmaceutical industry has a golden opportunity to use its expertise to truly enhance lives. Going beyond the pill is proving to be a win/win for patients and pharma alike – because improved outcomes are better for everyone. Going beyond the pill.

Pharma 97

Pharma Management Healthcare Healthcare 97

Medgadget

DECEMBER 21, 2022

The condition can be debilitating and life altering, and is progressive. Many heart failure patients must undergo repeat hospital admission as their condition deteriorates. Finding a way to monitor such patients while they are at home could yield dividends in terms of early intervention and better patient outcomes.

Patients 120

Patients Leads Medical 120

European Pharmaceutical Review

MARCH 30, 2023

AMR surveillance must improve, says WHO report… Terms of the exclusive licence agreement Under the agreement, GSK will make an upfront payment to SCYNEXIS of $90 million, plus additional potential milestone-based payments totalling $503 million. Currently, the treatment is in Phase III clinical trials for invasive candidiasis (IC).

Food and Drug Administration 94

Food and Drug Administration FDA Food Medicine 94

Medgadget

SEPTEMBER 29, 2023

The implant can be easily refilled from outside, allowing for long-term, minimally invasive drug treatment. Conn Hastings, Medgadget: Please give us an overview of the blood-brain barrier, and how it affects treatment for a variety of brain-based conditions. It is also wireless and can even be charged wirelessly.

Medicine 106

Medicine Distribution Specialization Medical 106

European Pharmaceutical Review

OCTOBER 23, 2023

Roche will also pay a near-term milestone payment of $150 million. The recent Phase IIb for RVT-3101 delivered the first long-term, robust dataset demonstrating improved clinical remission in the maintenance treatment phase,” stated Dr Levi Garraway, Roche’s Chief Medical Officer and Head of Global Product Development. “The

Safety 89

Safety Manufacturing Patients Medical 89

MaBiCo

FEBRUARY 20, 2023

The Benefits of a Sales Pilot for Pharmaceutical Products A sales pilot is a short-term experiment that tests a product’s sales performance or a new sales approach. Moreover, thanks to sales pilots, companies can adapt quickly to changing market conditions, can spot new opportunities and stay ahead of competition.

Pharmaceutical products 98

Pharmaceutical products Sales Pharmaceutical Competition 98

Pharmaceutical Technology

MARCH 28, 2023

Under the terms of the deal, the company will receive non-exclusive rights to CRISPR/Cas9, a gene-editing technology of CRISPR Therapeutics, for the development of potentially curative T1D cell therapies. It edits genes by precisely cutting DNA, then allowing natural DNA repair processes to take over.

Pharmaceutical 94

Pharmaceutical Leads Marketing Patients 94

Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, the company, through Astellas US Holding’s wholly owned subsidiary Berry Merger Sub, will acquire all the outstanding Iveric Bio shares for $40.00 Astellas Pharma has entered into a definitive agreement to buy US-based biopharmaceutical company Iveric bio, in a deal valued at nearly $5.9bn. in cash for each share.

Food and Drug Administration 111

Food and Drug Administration Pharma Food Networking 111

pharmaphorum

NOVEMBER 14, 2022

At the moment, treatment typically involves oral or topical corticosteroids, antihistamines, and some antidepressant drugs, but responses are often inadequate, vary widely between patients, and come with the burden of safety risks if used long-term. Sales of Dupixent rocketed 45% to around $2.4 Sales of Dupixent rocketed 45% to around $2.4

Sales 97

Sales Medicine Patients Leads 97

Pharmaceutical Technology

MAY 26, 2023

The MAAs include all indications covered by the Xgeva (denosumab) and Prolia (denosumab) reference medicines to treat conditions such as osteoporosis in postmenopausal women. Other conditions include the prevention of skeletal-related complications in cancer that has spread to the bones, as well as treatment-induced bone loss.

Food and Drug Administration 52

Food and Drug Administration Marketing Medicine Food 52

European Pharmaceutical Review

DECEMBER 22, 2023

Under the terms of the deal, BMS will acquire all outstanding shares of Karuna Therapeutics common stock for $330.00 The transaction is expected to close in the first half of 2024, subject to customary closing conditions. Bristol Myers Squibb (BMS) has agreed to acquire Karuna Therapeutics for a total of $14.0 per share in cash.

Food and Drug Administration 97

Food and Drug Administration Side effects Safety Food 97

Medgadget

MARCH 9, 2023

The technology could be particularly useful in identifying anemia in children in remote areas, as the condition can significantly affect their development. An affordable and reliable technique to screen for anemia using a smartphone could drive long-term improvements in quality of life for a large amount of people.”

Healthcare 108

Healthcare Healthcare Medical Patients 108

Pharmaceutical Technology

MARCH 20, 2023

The collaboration, under a sponsored research agreement, will focus on mRNA vaccines that can help in modulating the normal immune response of the body for the treatment of certain autoimmune diseases as well as allergic conditions. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Medicine 98

Medicine Food Leads Patients 98

Legacy MEDSearch

OCTOBER 25, 2023

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine. As for clinical efficacy, 74.1%

Side effects 52

Side effects Recruitment Networking Management 52

European Pharmaceutical Review

OCTOBER 19, 2022

Eli Lilly is set to acquire Akouos, Inc, a precision genetic medicine company developing first-in-class adeno-associated viral gene therapies for treating inner ear conditions like sensorineural hearing loss. . Under the terms of the deal, Lilly will acquire all outstanding shares of Akouos for $12.50 Dr Andrew C.

Medicine 95

Medicine Leads Medical Pharmaceutical 95

European Pharmaceutical Review

JANUARY 4, 2023

We are excited to collaborate with EVOQ [in our aim to address] the needs of people living with these conditions.”. Under the terms of the agreement, the sum EVOQ could potentially gain will come from upfront, option exercise and milestone payments across all programmes, as well as tiered royalties on product sales.

Sales 99

Sales Pharmaceutical 99